Jump to the main content block

Institute Characteristics

Institute Characteristics

The educational goal of our institute is to cultivate students with professional knowledge and technology related to molecular medicine, train students to have a rigorous research attitude and independent thinking ability, and train research professionals in molecular medicine and related fields. The research characteristics of our institute can be divided into three aspects:

Research in Cancer Biology

The NCKU Hospital currently has research groups for nasopharyngeal cancer, oral cancer, liver cancer, breast cancer, cervical cancer, bladder cancer, lung cancer, and rectal cancer. Our teachers have joined these research groups to evaluate human drug sensitivity, and are engaged in research on anti-cancer drugs and cancer treatments. In addition, studying the molecular mechanisms of angiogenesis, cell apoptosis and tumor occurrence and metastasis is also an important topic of our tumor research.

Research in Genetics and Developmental Biology

Congenital and acquired mutations lead to gene dysregulation or protein function changes. In addition to genetic diseases, an increasing number of human diseases such as hypertension, diabetes and cancer also have genetic mutations. Therefore, using modern molecular/cytogenetics theories and techniques, our teachers have been engaged in the research of genetic and developmental diseases, including depression, the development, injury, and degeneration of nerve cells, and the treatment of diseases by stem cells. They also are engaged in research on cancer prevention for epigenetic and genetic inheritance.

Research in Infections Disease

Due to geographical, cultural and other unidentified factors, the incidence and tolerance of certain infectious diseases in southern Taiwan are different from other regions. Our institute joins a research group composed of experts from the university and the National Institutes of Health to discuss and study the pathogenic mechanism of cystitis bacteria and HIV, HCV and other viruses on the host, while developing new detection methods, therapeutic drugs and vaccines.